Medical Care Technologies Inc. (OTCID:MDCE) Moves $250,000 Software Agreement Into Active Development
The first payment has been initiated as the company moves its first paid external software engagement into technical delivery.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Medical Care Technologies (OTCID:MDCE) has begun development under its first paid external software agreement outside its subsidiaries, valued at up to $250,000.
The agreement, announced October 14, involves a client group that includes current and retired professional athletes. The first payment has been initiated, but is not described as received. Work covers an integrated web and enterprise software system, with consulting and administrative support during development, testing and deployment.
Separately, the company says a subsidiary is in the process of completing the largest agreement in the history of Medical Care Technologies and its subsidiaries. That agreement is not yet complete. Other work includes enterprise consulting for AI model training and internal evaluation of MDCE Melanoma Scan Beta and a wound-monitoring application.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Major pointUp to $250,000 software agreement has entered active development, marking the first paid external engagement outside subsidiaries. 77% of market cap
- Minor pointFirst payment under the software agreement has been initiated.
- Minor point. Forward-looking: it has not happened yet and may not happen.Ongoing consulting and administrative support are included during system development, testing and deployment.
- Minor pointAI model-training consulting and internal evaluation of melanoma-scan and wound-monitoring applications continue.
Negative
- Moderate pointSeparate subsidiary agreement remains incomplete; the company describes it as its largest across the parent and subsidiaries.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MESA, AZ / ACCESS Newswire / November 4, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today provided an execution update on the software agreement announced October 14, valued at up to
The engagement covers software development that includes a web-based interface integrated with a custom enterprise software system. The platform is being built with data models and workflow logic to manage inventory tracking, sales transactions, and related operational processes. Development includes backend system architecture, data integration points, and administrative modules that support ongoing configuration and operational use. The agreement also includes ongoing consulting and administrative support as the system is developed, tested, and deployed. This is the Company's first paid external software agreement outside of its subsidiaries.
"This is an exciting milestone that validates the value of our technological approach to software," said Marshall Perkins, CEO of Medical Care Technologies. "We moved from an announced agreement to active development on an integrated web and enterprise system with inventory and sales workflow logic, data models, and backend architecture. It shows the platform work can convert into paid technical delivery."
Separately, one of the Company's subsidiaries is in the process of completing the largest agreement in the history of Medical Care Technologies and all of its subsidiaries. No further details are being provided at this time.
The Company continues to advance other commercial tracks, including enterprise consulting for AI model training, subsidiary operations at Infinite Auctions and Real Game Used, and internal evaluation of MDCE Melanoma Scan Beta and the wound-monitoring application. No new software agreements are being announced in this release.
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTCID:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. The Company owns subsidiaries Infinite Auctions and Real Game Used. Visit: https://www.medicalcaretechnologies.com | https://infiniteauctions.com | https://realgameused.com
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding ongoing development under an existing agreement and a potential subsidiary arrangement. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.
Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: marshall@medicalcaretechnologies.com
Website: https://www.medicalcaretechnologies.com
SOURC: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is the value and status of MDCE's external software agreement?
The agreement is valued at up to $250,000, and technical development is underway. The first payment has been initiated. Announced October 14, it is Medical Care Technologies' first paid external software agreement outside its subsidiaries.
What will Medical Care Technologies build under its software agreement?
Medical Care Technologies is building a web-based interface integrated with a custom enterprise software system. Its data models and workflow logic will manage inventory tracking, sales transactions and related operational processes. Development also includes backend architecture, data integration points and administrative modules.